MarcYWassermanMD

PubMed

• 2 citations
  Practical Considerations in the Administration of Aducanumab for the Neurologist.
  Katherine Coerver, Melissa M Yu, Anelyssa D'Abreu, Marc Wasserman, Kavita V Nair> ;Neurology. Clinical Practice. 2022 Apr 1
• Beyond The Middle: Evaluating Surrogacy Of Clinical Trial Endpoints Across Trial Durations.
  Wasserman M, Amin A> ;Value Health. 2015-11-01
• Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Thera...
  Amin, A.,Cruz González, I.,Reddy, V.,Holmes, D.,Berti, S.,Iñiguez Romo, A.,De Deppo, L.,Priest, V.,Simmonds, M.,Lee, C.,Wasserman, M.,Margonato, A.> ;Value Health. 2015 Nov 05
• Qualitative and Quantitative Analysis of The Scottish Medicines Consortium (Smc) Advice.
  Lee, C.,Wasserman, M.,Arnaud, A.> ;Value Health. 2015 Nov 05
• Feasibility of Pharmacoeconomic Evaluations of Traditional Chinese Medicine from the Perspectives of the Health Insurance Review & Assessment Service in South Korea.
  Lee C, Wasserman M, Guan Q> ;Value Health. 2014-11-01
• Understanding the Need and Value of Surrogate Endpoints for Health Care Decision Making in Asia Pacific.
  Wasserman M, Lee C> ;Value Health. 2014-11-01
• The Effect of China's Basic Medical Insurance Schemes on Health Service Utilization.
  Lee C, Sun H, Guan Q, Wasserman M> ;Value Health. 2014-11-01
• Join now to see all